Cargando…
Quality Control of Immunological Veterinary Medicinal Products in Europe
Medicinal products in Europe are under the strict control of many organisations headed by the European Directorate for the Quality of Medicines and HealthCare (EDQM) in Strasbourg and its related General European Official Medicines Control Laboratories (OMCLs) Network (GEON). The EDQM works in coope...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950427/ https://www.ncbi.nlm.nih.gov/pubmed/31934671 http://dx.doi.org/10.2478/jvetres-2019-0075 |
_version_ | 1783486069302362112 |
---|---|
author | Pasik, Katarzyna Łysiak, Ewa |
author_facet | Pasik, Katarzyna Łysiak, Ewa |
author_sort | Pasik, Katarzyna |
collection | PubMed |
description | Medicinal products in Europe are under the strict control of many organisations headed by the European Directorate for the Quality of Medicines and HealthCare (EDQM) in Strasbourg and its related General European Official Medicines Control Laboratories (OMCLs) Network (GEON). The EDQM works in cooperation with the European Medicines Agency (EMA) and the World Health Organisation (WHO). All of these institutions have one main goal – to protect public health in Europe and around the world. One of the more important effects of the harmonisation of pharmaceutical law in Europe was the introduction of the mutual recognition principle for the Official Control Authority Batch Release (OCABR)/Official Batch Protocol Review (OBPR) certificates in the European Union. The National Veterinary Research Institute (NVRI) in Poland is an example of an OMCL laboratory within the Veterinary Batch Release Network (VBRN) that issues the European certificates. The NVRI is actively involved in the batch release of immunological veterinary medicinal products (IVMPs), with approximately 1,800 certificates for IVMPs issued per year. It is also one of only four veterinary OMCLs that perform Post Marketing Surveillance (PMS) studies including approximately 47 IVMPs per year. All the results of the testing data are sent to the Chief Veterinary Officer, and also to the electronic Network platforms of the EDQM, which enables transparent information exchange. |
format | Online Article Text |
id | pubmed-6950427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Sciendo |
record_format | MEDLINE/PubMed |
spelling | pubmed-69504272020-01-13 Quality Control of Immunological Veterinary Medicinal Products in Europe Pasik, Katarzyna Łysiak, Ewa J Vet Res Review Article Medicinal products in Europe are under the strict control of many organisations headed by the European Directorate for the Quality of Medicines and HealthCare (EDQM) in Strasbourg and its related General European Official Medicines Control Laboratories (OMCLs) Network (GEON). The EDQM works in cooperation with the European Medicines Agency (EMA) and the World Health Organisation (WHO). All of these institutions have one main goal – to protect public health in Europe and around the world. One of the more important effects of the harmonisation of pharmaceutical law in Europe was the introduction of the mutual recognition principle for the Official Control Authority Batch Release (OCABR)/Official Batch Protocol Review (OBPR) certificates in the European Union. The National Veterinary Research Institute (NVRI) in Poland is an example of an OMCL laboratory within the Veterinary Batch Release Network (VBRN) that issues the European certificates. The NVRI is actively involved in the batch release of immunological veterinary medicinal products (IVMPs), with approximately 1,800 certificates for IVMPs issued per year. It is also one of only four veterinary OMCLs that perform Post Marketing Surveillance (PMS) studies including approximately 47 IVMPs per year. All the results of the testing data are sent to the Chief Veterinary Officer, and also to the electronic Network platforms of the EDQM, which enables transparent information exchange. Sciendo 2019-12-19 /pmc/articles/PMC6950427/ /pubmed/31934671 http://dx.doi.org/10.2478/jvetres-2019-0075 Text en © 2019 K. Pasik, E. Łysiak et al. published by Sciendo http://creativecommons.org/licenses/by-nc-nd/3.0 This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. |
spellingShingle | Review Article Pasik, Katarzyna Łysiak, Ewa Quality Control of Immunological Veterinary Medicinal Products in Europe |
title | Quality Control of Immunological Veterinary Medicinal Products in Europe |
title_full | Quality Control of Immunological Veterinary Medicinal Products in Europe |
title_fullStr | Quality Control of Immunological Veterinary Medicinal Products in Europe |
title_full_unstemmed | Quality Control of Immunological Veterinary Medicinal Products in Europe |
title_short | Quality Control of Immunological Veterinary Medicinal Products in Europe |
title_sort | quality control of immunological veterinary medicinal products in europe |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950427/ https://www.ncbi.nlm.nih.gov/pubmed/31934671 http://dx.doi.org/10.2478/jvetres-2019-0075 |
work_keys_str_mv | AT pasikkatarzyna qualitycontrolofimmunologicalveterinarymedicinalproductsineurope AT łysiakewa qualitycontrolofimmunologicalveterinarymedicinalproductsineurope |